{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:40:56Z","timestamp":1791168056835,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,6]],"date-time":"2010-03-06T00:00:00Z","timestamp":1267833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00204-010-0527-7","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T10:02:16Z","timestamp":1267783336000},"page":"263-270","source":"Crossref","is-referenced-by-count":14,"title":["Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia"],"prefix":"10.1007","volume":"84","author":[{"given":"Jeffrey F.","family":"Waring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ciurlionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennan","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"DeGoey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Spear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale J.","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,6]]},"reference":[{"key":"527_CR1","doi-asserted-by":"crossref","first-page":"13120","DOI":"10.1073\/pnas.95.22.13120","volume":"95","author":"P Andre","year":"1998","unstructured":"Andre P, Groettrup M, Klenerman P, de Giuli R, Booth BL Jr, Cerundolo V, Bonneville M, Jotereau F, Zinkernagel RM, Lotteau V (1998) An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc Natl Acad Sci USA 95:13120\u201313124","journal-title":"Proc Natl Acad Sci USA"},{"key":"527_CR2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"issue":"528\u201332","key":"527_CR3","first-page":"537","volume":"15","author":"CJ Cohen","year":"2005","unstructured":"Cohen CJ (2005) Ritonavir-boosted protease inhibitors, Part 2: cardiac implications of lipid alterations. AIDS Read 15(528\u201332):537\u2013538","journal-title":"AIDS Read"},{"key":"527_CR4","unstructured":"DeGoey DA, Flosi WJ, Grampovnik DJ, Flentge CA, Klein LL, Yeung CM, Colletti L, Dekhtyar T, Kati WM, Mo H, Liu Y, Ciurlionis R, Long MA, Marsh KC, Schmidt JM, Swanson SJ, Waring JF, Molla A, Kempf DJ (2008) Discovery of new HIV protease inhibitors and prodrug strategies for enhancing their oral bioavailability. In 236th ACS National Meeting, Philadelphia, PA"},{"key":"527_CR5","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/jm900044w","volume":"52","author":"DA Degoey","year":"2009","unstructured":"Degoey DA, Grampovnik DJ, Flentge CA, Flosi WJ, Chen HJ, Yeung CM, Randolph JT, Klein LL, Dekhtyar T, Colletti L, Marsh KC, Stoll V, Mamo M, Morfitt DC, Nguyen B, Schmidt JM, Swanson SJ, Mo H, Kati WM, Molla A, Kempf DJ (2009) 2-Pyridyl P1\u2019-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. J Med Chem 52:2571\u20132586","journal-title":"J Med Chem"},{"key":"527_CR6","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1021\/jo060737s","volume":"71","author":"K Engstrom","year":"2006","unstructured":"Engstrom K, Henry R, Hollis LS, Kotecki B, Marsden I, Pu YM, Wagaw S, Wang W (2006) An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611. J Org Chem 71:5369\u20135372","journal-title":"J Org Chem"},{"key":"527_CR7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(06)69155-1","volume":"368","author":"J Eron Jr","year":"2006","unstructured":"Eron J Jr, Yeni P, Gathe J Jr, Estrada V, DeJesus E, Staszewski S, Lackey P, Katlama C, Young B, Yau L, Sutherland-Phillips D, Wannamaker P, Vavro C, Patel L, Yeo J, Shaefer M (2006) The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48\u00a0weeks: a randomised non-inferiority trial. Lancet 368:476\u2013482","journal-title":"Lancet"},{"key":"527_CR8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/088922203771881248","volume":"19","author":"ES Goetzman","year":"2003","unstructured":"Goetzman ES, Tian L, Nagy TR, Gower BA, Schoeb TR, Elgavish A, Acosta EP, Saag MS, Wood PA (2003) HIV protease inhibitor ritonavir induces lipoatrophy in male mice. AIDS Res Hum Retroviruses 19:1141\u20131150","journal-title":"AIDS Res Hum Retroviruses"},{"key":"527_CR9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.sbi.2003.10.005","volume":"13","author":"M Groll","year":"2003","unstructured":"Groll M, Clausen T (2003) Molecular shredders: how proteasomes fulfill their role. Curr Opin Struct Biol 13:665\u2013673","journal-title":"Curr Opin Struct Biol"},{"key":"527_CR10","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1016\/j.febslet.2007.03.053","volume":"581","author":"J Hanna","year":"2007","unstructured":"Hanna J, Finley D (2007) A proteasome for all occasions. FEBS Lett 581:2854\u20132861","journal-title":"FEBS Lett"},{"key":"527_CR11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/dmd.107.019547","volume":"36","author":"C Healan-Greenberg","year":"2008","unstructured":"Healan-Greenberg C, Waring JF, Kempf DJ, Blomme EA, Tirona RG, Kim RB (2008) A human immunodeficiency virus protease inhibitor is a novel functional inhibitor of human pregnane X receptor. Drug Metab Dispos 36:500\u2013507","journal-title":"Drug Metab Dispos"},{"key":"527_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002030-200101260-00013","volume":"15","author":"KV Heath","year":"2001","unstructured":"Heath KV, Hogg RS, Chan KJ, Harris M, Montessori V, O\u2019Shaughnessy MV, Montanera JS (2001) Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV\/AIDS treatment database. Aids 15:231\u2013239","journal-title":"Aids"},{"key":"527_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7827(02)00046-2","volume":"42","author":"DY Hui","year":"2003","unstructured":"Hui DY (2003) Effects of HIV protease inhibitor therapy on lipid metabolism. Prog Lipid Res 42:81\u201392","journal-title":"Prog Lipid Res"},{"key":"527_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11904-996-0008-z","volume":"2","author":"GA Lee","year":"2005","unstructured":"Lee GA, Rao MN, Grunfeld C (2005) The effects of HIV protease inhibitors on carbohydrate and lipid metabolism. Curr HIV\/AIDS Rep 2:39\u201350","journal-title":"Curr HIV\/AIDS Rep"},{"key":"527_CR15","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1093\/jn\/130.9.2361","volume":"130","author":"JM Lenhard","year":"2000","unstructured":"Lenhard JM, Croom DK, Weiel JE, Spaltenstein A, Reynolds DJ, Furfine ES (2000a) Dietary fat alters HIV protease inhibitor-induced metabolic changes in mice. J Nutr 130:2361\u20132366","journal-title":"J Nutr"},{"key":"527_CR16","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","volume":"20","author":"JM Lenhard","year":"2000","unstructured":"Lenhard JM, Croom DK, Weiel JE, Winegar DA (2000b) HIV protease inhibitors stimulate hepatic triglyceride synthesis. Arterioscler Thromb Vasc Biol 20:2625\u20132629","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"527_CR17","doi-asserted-by":"crossref","first-page":"49066","DOI":"10.1074\/jbc.M107250200","volume":"76","author":"CP Liang","year":"2001","unstructured":"Liang CP, Tall AR (2001) Transcriptional profiling reveals global defects in energy metabolism, lipoprotein and bile acid synthesis and transport with reversal by leptin treatment in ob\/ob mouse liver. J Biol Chem 76:49066\u201349076","journal-title":"J Biol Chem"},{"key":"527_CR18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/46.5.673","volume":"46","author":"ES Lightcap","year":"2000","unstructured":"Lightcap ES, McCormack TA, Pien CS, Chau V, Adams J, Elliott PJ (2000) Proteasome inhibition measurements: clinical application. Clin Chem 46:673\u2013683","journal-title":"Clin Chem"},{"key":"527_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.108.138131","volume":"326","author":"S Lu","year":"2008","unstructured":"Lu S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J (2008) Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma\/leukemia line. J Pharmacol Exp Ther 326:423\u2013431","journal-title":"J Pharmacol Exp Ther"},{"key":"527_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ygeno.2007.06.004","volume":"90","author":"PY Lum","year":"2007","unstructured":"Lum PY, He YD, Slatter JG, Waring JF, Zelinsky N, Cavet G, Dai X, Fong O, Gum R, Jin L, Adamson GE, Roberts CJ, Olsen DB, Hazuda DJ, Ulrich RG (2007) Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia. Genomics 90:464\u2013473","journal-title":"Genomics"},{"key":"527_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-5793(99)00467-6","volume":"450","author":"G Mannhaupt","year":"1999","unstructured":"Mannhaupt G, Schnall R, Karpov V, Vetter I, Feldmann H (1999) Rpn4p acts as a transcription factor by binding to PACE, a nonamer box found upstream of 26S proteasomal and other genes in yeast. FEBS Lett 450:27\u201334","journal-title":"FEBS Lett"},{"key":"527_CR22","doi-asserted-by":"crossref","first-page":"21517","DOI":"10.1074\/jbc.M301032200","volume":"278","author":"S Meiners","year":"2003","unstructured":"Meiners S, Heyken D, Weller A, Ludwig A, Stangl K, Kloetzel PM, Kruger E (2003) Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes. J Biol Chem 278:21517\u201321525","journal-title":"J Biol Chem"},{"key":"527_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(98)00011-4","volume":"39","author":"A Molla","year":"1998","unstructured":"Molla A, Granneman GR, Sun E, Kempf DJ (1998) Recent developments in HIV protease inhibitor therapy. Antiviral Res 39:1\u201323","journal-title":"Antiviral Res"},{"key":"527_CR24","first-page":"5230","volume":"62","author":"F Pajonk","year":"2002","unstructured":"Pajonk F, Himmelsbach J, Riess K, Sommer A, McBride WH (2002) The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. Cancer Res 62:5230\u20135235","journal-title":"Cancer Res"},{"key":"527_CR25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella Jr","year":"1998","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 338:853\u2013860","journal-title":"N Engl J Med"},{"key":"527_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11883-008-0010-6","volume":"10","author":"V Pao","year":"2008","unstructured":"Pao V, Lee GA, Grunfeld C (2008) HIV therapy, metabolic syndrome, and cardiovascular risk. Curr Atheroscler Rep 10:61\u201370","journal-title":"Curr Atheroscler Rep"},{"key":"527_CR27","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","volume":"276","author":"TM Riddle","year":"2001","unstructured":"Riddle TM, Kuhel DG, Woollett LA, Fichtenbaum CJ, Hui DY (2001) HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. J Biol Chem 276:37514\u201337519","journal-title":"J Biol Chem"},{"key":"527_CR28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1194\/jlr.M200129-JLR200","volume":"43","author":"TM Riddle","year":"2002","unstructured":"Riddle TM, Schildmeyer NM, Phan C, Fichtenbaum CJ, Hui DY (2002) The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice. J Lipid Res 43:1458\u20131463","journal-title":"J Lipid Res"},{"key":"527_CR33","doi-asserted-by":"crossref","first-page":"35734","DOI":"10.1074\/jbc.274.50.35734","volume":"274","author":"G Schmidtke","year":"1999","unstructured":"Schmidtke G, Holzhutter HG, Bogyo M, Kairies N, Groll M, de Giuli R, Emch S, Groettrup M (1999) How an inhibitor of the HIV-I protease modulates proteasome activity. J Biol Chem 274:35734\u201335740","journal-title":"J Biol Chem"},{"key":"527_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaci.2008.05.033","volume":"122","author":"L Shen","year":"2008","unstructured":"Shen L, Siliciano RF (2008) Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol 122:22\u201328","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"527_CR30","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/00126334-200310012-00005","volume":"34","author":"R Sherer","year":"2003","unstructured":"Sherer R (2003) HIV, HAART, and hyperlipidemia: balancing the effects. J Acquir Immune Defic Syndr 34(Suppl 2):S123\u2013S129","journal-title":"J Acquir Immune Defic Syndr"},{"key":"527_CR31","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1073\/pnas.071022298","volume":"98","author":"Y Xie","year":"2001","unstructured":"Xie Y, Varshavsky A (2001) RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit. Proc Natl Acad Sci USA 98:3056\u20133061","journal-title":"Proc Natl Acad Sci USA"},{"key":"527_CR32","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2005.11.021","volume":"44","author":"P Yeni","year":"2006","unstructured":"Yeni P (2006) Update on HAART in HIV. J Hepatol 44:S100\u2013S103","journal-title":"J Hepatol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-010-0527-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-010-0527-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-010-0527-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T22:58:34Z","timestamp":1590706714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-010-0527-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s00204-010-0527-7","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,6]]}}}